BS-008

N/A

Report date: 2026/03/23 17:56:30

Base Information

Drug NameBS-008
Drug Alias NameRecombinant human GM-CSF oncolytic herpes simplex virus type 2 (OH2)/BS-006BS001 combo with αPD-1BS001/BS006BS001+BS006
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionColony stimulating factor 1 receptor stimulants
TargetsColony stimulating factor 1 receptor
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesWuhan Binhui Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Binhui Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsSarcoma
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A